Medozil Capsule combines Memantine (14 mg) and Donepezil (10 mg) to provide a dual therapeutic approach for managing Alzheimer’s disease and other forms of dementia. This combination targets both the cholinergic and glutamatergic pathways in the brain, which are commonly disrupted in neurodegenerative disorders, helping improve cognitive function, daily living activities, and behavioral symptoms.
Donepezil is a cholinesterase inhibitor that enhances acetylcholine levels in the brain, improving neuronal communication. Memantine is an NMDA receptor antagonist that protects neurons from excitotoxic damage caused by excessive glutamate activity. Together, they offer complementary benefits for patients with moderate to severe Alzheimer’s disease.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Medozil Capsule 14 mg+10 mg is indicated for:
Treatment of moderate to severe Alzheimer’s disease
Improvement of cognitive function, memory, and attention in dementia patients
Management of behavioral and psychological symptoms associated with neurodegenerative disorders
Support for daily living activities in patients with progressive memory loss
Donepezil:
Inhibits acetylcholinesterase, the enzyme responsible for breaking down acetylcholine
Increases acetylcholine availability in synaptic clefts
Enhances communication between neurons in the brain regions involved in memory and learning
Memantine:
Acts as an NMDA receptor antagonist
Regulates excessive glutamate activity, preventing neuronal excitotoxicity
Helps slow neurodegeneration and preserve cognitive function
The combination provides symptomatic relief and may slow disease progression compared to monotherapy.
Medozil Capsule should be taken orally, once daily, preferably at the same time each day.
Capsules can be taken with or without food.
Standard dosing: 14 mg Memantine + 10 mg Donepezil as prescribed by a physician, based on patient tolerance and severity of disease.
Patients should not abruptly discontinue therapy, as this may lead to worsening of symptoms.
Dosage adjustments may be necessary in cases of renal impairment or elderly patients.
Improves memory, attention, and overall cognitive function
Reduces behavioral disturbances and agitation associated with dementia
Supports daily living activities and quality of life
Dual-action therapy targeting both cholinergic deficiency and glutamatergic excitotoxicity
Use cautiously in patients with cardiac disorders, seizures, or liver impairment
Monitor for bradycardia, gastrointestinal bleeding, or severe dizziness
May interact with other cholinergic or NMDA-acting drugs
Not recommended for patients with hypersensitivity to Memantine, Donepezil, or any capsule component
Common side effects may include:
Nausea, vomiting, diarrhea, or constipation
Dizziness, headache, or fatigue
Insomnia or vivid dreams
Muscle cramps or weakness
Rare: arrhythmias, hypotension, or allergic reactions
Most side effects are mild and transient; persistent or severe reactions require medical attention.
Store in a cool, dry place below 30°C
Protect from light and moisture
Keep out of reach of children
Pregnancy and Lactation: Should be used only if clearly necessary and under medical supervision.
Geriatric Patients: Typically well-tolerated; dose adjustments may be required based on renal function.
Login Or Registerto submit your questions to seller
No none asked to seller yet